Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Health Aff (Millwood). 2017 Dec;36(12):2151–2159. doi: 10.1377/hlthaff.2017.0228

EXHIBIT 2.

EXHIBIT 2

Predicted increases in costs per quality-adjusted life-year (QALY) gained if coinsurance for colorectal cancer screening were waived, by percentage-point increase in adherence to screening, diagnostic follow-up, and surveillance.